Evidence map›Paper›PMID 12708472›Full record

ArticleCancer science2003

Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma.

Katsumi Higashino, Tsutomu Narita, Takashi Taga, Shigeru Ohta, Yoshihiro Takeuchi

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cancer science, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katsumi HigashinoDepartment of Pediatrics, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga 520-2192.
Tsutomu Narita
Takashi Taga
Shigeru Ohta
Yoshihiro Takeuchi
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant rhabdoid tumors (MRT) show a multiphenotypic diversity, including a neural phenotype. To elucidate the difference in neural characteristics between MRT and neuroblastoma, we examined the expression of synapsin I, neuron-restrictive silencer factor (NRSF), neurofilament medium-size (NF-M) and chromogranin A (CGA) in five MRT cell lines (TM87-16, STM91-01, TTC549, TTC642 and YAM-RTK1) and five neuroblastoma cell lines under differentiation-induction with 12-O-tetradecanoylphorbol-13-acetate (TPA). Our results showed TM87-16 and TTC642 cells, expressed synapsin I and NF-M before TPA induction, had a neural phenotype. After differentiation-induction, only TM87-16 cells expressed CGA. Among all neuroblastoma cells, expression of NF-M and CGA was stable at a high level throughout TPA-induced differentiation. In TM87-16 and TTC642 MRT cells, synapsin I mRNA promptly increased after TPA differentiation, with the peak level at 6 h, and thereafter, synapsin I mRNA rapidly decreased in a time-dependent manner. The decreased expression of synapsin I correlated with an increased expression of NRSF during differentiation-induction. In contrast, in some neuroblastoma cells, a significant up-regulation of synapsin I was observed concurrently with a down-regulation of NRSF. The inverse relationship between NRSF and synapsin I expression in TM87-16 and TTC642 MRT cells was opposite to that of neuroblastoma cells. Our results showed that the neural characteristics of these MRT cells are fairly distinct from those of neuroblastoma cells. These MRT cells appeared to have only limited capability for neural differentiation, and were still in an extremely early stage of neural differentiation.

Indexed as

Cell DifferentiationChromogranin AChromograninsGene Expression ProfilingGene Expression Regulation, NeoplasticIn Situ HybridizationNeoplasm ProteinsNerve Tissue ProteinsNeuroblastomaNeurofilament ProteinsNeuronsRE1-Silencing Transcription FactorRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionRhabdoid TumorRNA, MessengerChromogranin AChromograninsNeoplasm ProteinsNerve Tissue Proteinsneurofilament protein MNeurofilament ProteinsRE1-Silencing Transcription FactorRepressor ProteinsRNA, MessengerRNA, NeoplasmSynapsinsTetradecanoylphorbol AcetateTranscription Factors

Identifiers

PMID12708472
PMCPMC11160256
OpenAlexW2019804935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.